What is the role of cord blood transplantation in the treatment of cutaneous T-cell lymphoma (CTCL)?

Updated: Aug 15, 2018
  • Author: Lauren C Pinter-Brown, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Unrelated cord blood transplantation is a possible therapeutic option. [19] In one patient, it was performed following myeloablative conditioning and brought a complete remission. Although a relapse occurred 3 months later, discontinuation of immunosuppressant therapy led to mycosis fungoides regression and a second complete remission that continued for more than 23 months. Reduced-intensity umbilical cord blood transplantation is another option for advanced mycosis fungoides. [98]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!